Extent of surgery for phaeochromocytomas in the genomic era.
H M RossittiP SöderkvistOliver GimmPublished in: The British journal of surgery (2018)
Adrenal-sparing surgery should be the standard approach for patients who have already been diagnosed with MEN2 or VHL when operating on the first side, whereas complete removal of the affected adrenal gland(s) is generally recommended for patients with SDHB or MAX germline mutations. Routine assessment of a patient's genotype, even after the first operation, can be crucial for adopting an appropriate strategy for follow-up and future surgery.
Keyphrases
- minimally invasive
- coronary artery bypass
- end stage renal disease
- surgical site infection
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- robot assisted
- percutaneous coronary intervention
- coronary artery disease
- oxidative stress
- current status
- dna repair
- acute coronary syndrome
- dna damage
- clinical practice
- atrial fibrillation
- patient reported